When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” ...

GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.

With more Black women over 40 using GLP-1s, we break down the risks when it comes to micro-dosing the drug for menopausal ...

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential ...

Background The carbon footprint of end-to-end healthcare deliveries by the National Health Service in England totalled 25.0 megatons of carbon dioxide equivalent (CO2e) in 2019. Optimal and ...

Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.

We hear the refrain again this year from and about Democrats’ chances to retake the Senate: “It’s a bad map.” It was a bad ...

Researchers have found in a new study that adults with type 2 diabetes and cancer who used GLP-1 receptor agonists had a ...

Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering.The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...

Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved the oral version of Wegovy® on December 22, 2025. The oral tablet, also known ...

A new study published in the journal Cell Metabolism strongly suggests that low doses of weight loss drugs like Ozempic and Zepbound can counteract aging in middle-aged mice, adding to the growing ...

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye complications for people with obesity and diabetes. Over 10 years, patients ...